drugset / Trial / NCT00182169

Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure

NCT00182169 ↗

Phase 2 Completed 80 enrolled Hamilton Health Sciences Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

Prospective randomized, placebo controlled, clinical trial to evaluate the effect of human growth hormone supplementation compared with placebo to patients with severe heart failure for a duration of 6 months on exercise capacity, heart function and quality of life

Timeline

Start
1997-07
Primary completion
—
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Human recombinant growth hormone Protein / enzyme biologic — —

Indications